IMMUNE OS ATLASby AllerimSign in

Atlas evidence ledger

Show what supports the story—and what it cannot prove.

Public Atlas journeys carry a version, review date, source anchors, uncertainties, clinical-risk label, and visible change record. External databases enrich the curated Atlas graph; they do not replace it or update it automatically.

3

versioned journeys

9

source anchors

2026-07-12

latest review

2

reviews due

0

stale records

Publication rules

01

New evidence enters as a proposal, not an automatic graph change.

02

Evidence strength and clinical risk stay separate.

03

Uncertainty is part of the published record.

04

Material changes receive a versioned explanation.

05

Atlas output does not directly execute patient or provider workflows.

01 · v1.0

The alpha-gal delay

Reviewed 2026-07-12 · 3 sources · guideline evidence

Owner Mark Pruitt · next review 2026-08-12 · stale on 2026-09-12

review dueOpen record

Latest change

Created a source-anchored public journey from the existing Alpha-gal, mast-cell, and IgE-ratio Atlas nodes.

02 · v1.0

Barrier alarm to allergy

Reviewed 2026-07-12 · 3 sources · review evidence

Owner Mark Pruitt · next review 2026-10-12 · stale on 2026-11-12

Latest change

Created a public tissue-to-signal-to-cell-to-pattern journey with current type 2 review anchors.

03 · v1.0

Airway bacterial defense

Reviewed 2026-07-12 · 3 sources · review evidence

Owner Mark Pruitt · next review 2026-08-12 · stale on 2026-09-12

review dueOpen record

Latest change

Created a public airway-defense journey emphasizing recruitment, antimicrobial function, resolution, and tissue-injury boundaries.

Atlas records only aggregate daily counts for public journey and evidence interactions. It does not send identifiers, patient data, free text, search terms, cookies, IP addresses, or user-agent strings into the analytics record.